Remi Fromentin

12PUBLICATIONS
92CO-AUTHORS
Major global burdens of diseaseGenome structure and regulationNanotoxicology, health and safetyMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 12, 2026
Plasma GDF-15 levels are associated with HIV reservoir markers independently of inflammation in people with HIV on antiretroviral therapy.

Stephane Isnard, Lena Royston, Carolina A Berini

|Feb 27, 2023
Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes.

Caroline Dufour, Corentin Richard, Marion Pardons

|Jan 26, 2022
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy.

Thomas S Uldrick, Scott V Adams, Remi Fromentin

|Jan 18, 2022
The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription.

Afam A Okoye, Rémi Fromentin, Hiroshi Takata

|Dec 02, 2021
Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.

Chris Y Chiu, Judy J Chang, Ashanti I Dantanarayana

|Nov 26, 2021
Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality.

Elsa Brunet-Ratnasingham, Sai Priya Anand, Pierre Gantner

Pageof 2

Frequent Collaborators

12 joint publications

Nicolas Chomont

4 joint publications

Jean-Pierre Routy

3 joint publications

Sharon R Lewin

2 joint publications

Rachel Pascoe